Mason R. Firpo

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones et al. · Science · 2021 · 246 citations · Full text

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>

Nir Drayman, Krysten A. Jones, Saara‐Anne Azizi et al. · 2020 · 41 citations · Full text

Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry

Mason R. Firpo, Vincent Mastrodomenico, Grant M. Hawkins et al. · ACS Infectious Diseases · 2020 · 41 citations · Full text

Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening

Zachary J. Sandler, Mason R. Firpo, Oreoluwa S. Omoba et al. · Antimicrobial Agents and Chemotherapy · 2020 · 34 citations · Full text

Potassium Ions, Novel Ionophores Active, Molecular Virology +13

Polyamines and eIF5A hypusination facilitate SREBP2 synthesis and cholesterol production leading to enhanced enterovirus attachment and infection

Mason R. Firpo, Natalie J. LoMascolo, Marine J. Petit et al. · PLoS Pathogens · 2023 · 11 citations · Full text